Literature DB >> 17106919

Bacteria, inflammation, and colon cancer.

Liying Yang, Zhiheng Pei.   

Abstract

Our relationship with the colonic bacterial flora has long been viewed as benign, but recent studies suggest that this symbiosis has risks as well as benefits. This relationship requires that the host not only provide a supportive environment for the symbiotic bacteria, but also actively maintain intact mechanisms for properly managing the physiologic stresses that are closely associated with the symbiont's essential survival functions. Failure to do so breaches the host-symbiont contract, and can result in serious effects on the health of the host. Recent investigations that employ several knockout mouse models reveal the consequences of genetic deficiency in the host regarding these mechanisms, and the latent, pro-inflammatory, tumorigenic nature of normal bacterial flora. Further study of the interactions between normal bacterial flora and hosts could shed light on the etiologies and pathogenesis of inflammatory diseases and related cancers, with implications for human health.

Entities:  

Mesh:

Year:  2006        PMID: 17106919      PMCID: PMC4087425          DOI: 10.3748/wjg.v12.i42.6741

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

Review 1.  Pathology of mouse models of intestinal cancer: consensus report and recommendations.

Authors:  Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Tom Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven H Itzkowitz; Joanna Groden; Robert J Coffey
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Diversity of the human intestinal microbial flora.

Authors:  Paul B Eckburg; Elisabeth M Bik; Charles N Bernstein; Elizabeth Purdom; Les Dethlefsen; Michael Sargent; Steven R Gill; Karen E Nelson; David A Relman
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

Review 3.  Biology of the adenomatous polyposis coli tumor suppressor.

Authors:  K H Goss; J Groden
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

4.  Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice.

Authors:  D M McCafferty; E Sihota; M Muscara; J L Wallace; K A Sharkey; P Kubes
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-07       Impact factor: 4.052

Review 5.  The role of probiotic cultures in the prevention of colon cancer.

Authors:  L J Brady; D D Gallaher; F F Busta
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

6.  Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.

Authors:  L A Dieleman; A Arends; S L Tonkonogy; M S Goerres; D W Craft; W Grenther; R K Sellon; E Balish; R B Sartor
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Promotion of intestinal carcinogenesis by Streptococcus bovis.

Authors:  S Ellmerich; M Schöller; B Duranton; F Gossé; M Galluser; J P Klein; F Raul
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

8.  CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.

Authors:  Susan E Erdman; Theofilos Poutahidis; Michal Tomczak; Arlin B Rogers; Kathleen Cormier; Benjamin Plank; Bruce H Horwitz; James G Fox
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

9.  Bacterial biota in the human distal esophagus.

Authors:  Zhiheng Pei; Edmund J Bini; Liying Yang; Meisheng Zhou; Fritz Francois; Martin J Blaser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

10.  Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).

Authors:  Jordane Biarc; Isabelle S Nguyen; Annelise Pini; Francine Gossé; Sophie Richert; Danielle Thiersé; Alain Van Dorsselaer; Emmanuelle Leize-Wagner; Francis Raul; Jean-Paul Klein; Marie Schöller-Guinard
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

View more
  38 in total

1.  Perspective: alpha-bugs, their microbial partners, and the link to colon cancer.

Authors:  Cynthia L Sears; Drew M Pardoll
Journal:  J Infect Dis       Date:  2010-12-08       Impact factor: 5.226

2.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

3.  Human gut microbiome and risk for colorectal cancer.

Authors:  Jiyoung Ahn; Rashmi Sinha; Zhiheng Pei; Christine Dominianni; Jing Wu; Jianxin Shi; James J Goedert; Richard B Hayes; Liying Yang
Journal:  J Natl Cancer Inst       Date:  2013-12-06       Impact factor: 13.506

Review 4.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

Review 5.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

6.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

7.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

8.  Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.

Authors:  Inna Sekirov; Nicola M Tam; Maria Jogova; Marilyn L Robertson; Yuling Li; Claudia Lupp; B Brett Finlay
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells.

Authors:  Lobke Snoeks; Christopher R Weber; Jerrold R Turner; Mitra Bhattacharyya; Kaarin Wasland; Suzana D Savkovic
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.